The stock's rise snapped a three-day losing streak.
ResMed (NYSE:RMD) has had a rough month with its share price down 7.5%. However, stock prices are usually driven by ...
1d
Hosted on MSNWhat Are Wall Street Analysts’ Target Price for ResMed Stock?ResMed Inc. (RMD), headquartered in San Diego, California, manufactures, distributes, and markets medical devices and ...
New insights from 30,026 people across 13 markets show the global scale of poor sleep and its impact on health, work, and relationships7 out of 10 employed respondents have called in sick at least onc ...
Shares of ResMed Inc. RMD slipped 1.03% to $230.58 Tuesday, on what proved to be an all-around great trading session for the ...
ResMed’s strong demand for AirSense 11 boosts its earnings outlook. Learn why RMD stock is undervalued with growth opportunities in the sleep apnea market.
ResMed Inc. (NYSE:RMD – Free Report) – Zacks Research reduced their Q4 2026 earnings per share (EPS) estimates for shares of ResMed in a research note issued on Wednesday, February 19th.
Equities researchers at Zacks Research raised their Q3 2025 earnings per share estimates for ResMed in a report issued on Wednesday, February 19th. Zacks Research analyst R. Department now anticipates ...
Brett Fishbin; Analyst; KeyBanc Capital Markets Inc. Welcome to the Q2 fiscal-year 2025 ResMed earnings conference call. My name is Matt and I'll be your operator for today's call. (Operator ...
ResMed Inc. (NYSE: RMD, ASX: RMD) today announced results for its quarter ended December 31, 2024. Second Quarter 2025 Highlights All comparisons are to the prior year period “Our second quarter ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results